Details

Autor(en) / Beteiligte

• Suryavanshi, Sachin V
• Garud, Mayuresh S
• Barve, Kalyani
• Addepalli, Veeranjaneyulu
• Utpat, Sachin V
• Kulkarni, Yogesh A

Titel

Triphala Ameliorates Nephropathy via Inhibition of TGF-[beta]1 and Oxidative Stress in Diabetic Rats

Ist Teil von

• Pharmacology, 2020-11, Vol.105 (11-12), p.681

Ort / Verlag

S. Karger AG

Erscheinungsjahr

2020

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Introduction: Advanced glycation end products, oxidative stress, and TGF-[beta] expression play a crucial role in pathophysiology of diabetic nephropathy. Inhibition of oxidative stress and TGF-[beta] expression by natural traditional medicines may give an economic and safe alternative treatment option. Triphala churna, a traditional medicine, has been proved to have potent antioxidant activity, and individual components of it have shown significant antidiabetic activity. Hence, the present study was designed to study the effect of Triphala churna in diabetic nephropathy in rats. Methods: Diabetes was induced in rats by administration of streptozotocin (55 mg/kg i.p.). Four weeks after induction of diabetes, the animals were treated with Triphala churna at the doses of 250, 500, and 1,000 mg/kg for next 4 weeks. Various biochemical and urine parameters such as glucose, creatinine, blood urea nitrogen (BUN), total protein, and albumin were assessed at the end of study. Creatinine clearance, BUN clearance, and glomerular filtration rate were determined. Oxidative stress parameters such as malondialdehyde, catalase, reduced glutathione, and superoxide dismutase were determined in kidney tissues. TGF-[beta]1 expression was measured with ELISA, immunohistochemistry, and western blot techniques. Histopathology study was carried out with haemotoxylin and eosin, periodic acid-Schiff, and Masson's trichrome staining to determine histological changes. Results: Treatment with Triphala churna significantly improved urine parameters. Triphala churna treatment also improved plasma proteins, albumin, creatinine, and BUN levels. The oxidative stress was reduced in the kidney with the treatment of Triphala churna. Histopathological studies revealed that Triphala churna reduced kidney damage. Immunohistochemistry, ELISA, and western blotting study revealed that treatment with Triphala decreased the expression of TGF-[beta] in kidney tissues. Conclusion: From the results, it can be concluded that Triphala churna has a significant nephroprotective effect because of its capability of inhibiting oxidative stress and TGF-[beta] in diabetes. Keywords: Diabetic nephropathy, Triphala churna, Emblica officinalis, Terminalia belerica, Terminalia chebula, Diabetic complications